Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2010
06/10/2010WO2010027875A3 Compounds that modulate intracellular calcium
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145050 Orthogonally fixed compounds for electrooptical applications
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100144852 Bicyclo[2.2.1]hept-7-ylamine Derivatives and Their Uses
06/10/2010US20100144823 Novel indole derivatives as selective androgen receptor modulators (sarms)
06/10/2010US20100144812 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production Containing an Azole
06/10/2010US20100144810 Angiotensin ii receptor antagonists
06/10/2010US20100144798 Modulators of ATP-Binding Cassette Transporters
06/10/2010US20100144794 Insecticidal n-substituted (6-halooalkylpyridin-3-yl)-alkyl sulfoximines
06/10/2010US20100144762 Novel sulfonamides as l-cpt1 inhibitors
06/10/2010US20100144739 Heterocyclic inhibitors of c-met and uses thereof
06/10/2010US20100141122 Oled device with cyclobutene electron injection materials
06/10/2010US20100140597 Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors
06/10/2010CA2745356A1 2h-chromene compound and derivative thereof
06/10/2010CA2745095A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
06/10/2010CA2745019A1 Quinolone compound and pharmaceutical composition
06/10/2010CA2745015A1 Pharmaceutical agent comprising quinolone compound
06/10/2010CA2744152A1 Inhibitors of diacylglycerol acyltransferase
06/09/2010EP2194046A1 Triazolone derivative
06/09/2010EP2193122A1 Imidazole derivatives
06/09/2010EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
06/09/2010CN1989132B Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
06/09/2010CN1926108B Non-nucleotide reverse transcriptase inhibitors
06/09/2010CN1863789B Substituted isoquinolinones
06/09/2010CN1805935B Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1694874B Benzodiazepine derivatives and pharmaceutical compositions containing them
06/09/2010CN101730692A Pyridazinone derivatives useful as glucan synthase inhibitors
06/09/2010CN101730689A 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
06/09/2010CN101730684A sulfonyl-quinoline derivatives
06/09/2010CN101730680A 4' substituted compounds having 5-ht6 receptor affinity
06/09/2010CN101723937A imidazol-4-one and imidazole-4-thione compounds
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101721412A Methods of treating microbial infections in humans and animals
06/09/2010CN101239976B Dithienylethene compounds containing naphthalimide unit
06/08/2010US7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
06/08/2010US7732483 DNA-PK inhibitors
06/08/2010US7732466 5-chloro-thiophene-2-carboxylic acid-N-{1-[3-chloro-4-(pyrrolidin-1-yl-carbonyl)-phenylcarbamoly]-ethyl}-amide, having antithrombotic activity and blood-coagulation factor Xa inhibiting activity
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732452 Thiophene derivatives which are HM74A agonists
06/08/2010US7732448 pesticides such as 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine, having an excellent ability to control pests
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/03/2010WO2010062221A1 Substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids and ethers thereof and the use of same to treat viral diseases
06/03/2010WO2010060703A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
06/03/2010WO2010060702A1 Photoinitiator mixtures
06/03/2010WO2010060379A1 Ether compounds with nitrogen-containing 5-member heterocycle and the uses thereof
06/03/2010WO2010014257A3 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
06/03/2010WO2009154300A3 Heterocyclic compound and use thereof
06/03/2010US20100137604 Method of making piperidine derivatives
06/03/2010US20100137602 Process and intermediates for preparing arzoxifene
06/03/2010US20100137417 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses
06/03/2010US20100137402 N-[(4,5-diphenyl-2-thienyl)methyl]amine derivatives, their preparation and their therapeutic application
06/03/2010US20100137347 5-[3-((1S,2R)-2-{4-[1-(4-Methoxy-benzyloxy)-hexyl]-phenyl}-3-methylene-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester; glaucoma, inflammatory bowel disease, the stimulation of hair growth, and the stimulation of the conversion of vellus hair to terminal hair
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100136467 Oxime ester photoinitiators
06/03/2010CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists
06/02/2010EP2191825A1 Agent for fungal dermatitis
06/02/2010EP2190836A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
06/02/2010EP2190833A1 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
06/02/2010EP2190831A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
06/02/2010EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
06/02/2010EP2190822A2 5-membered heterocyclic compounds as proton pump inhibitors
06/02/2010EP2190820A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
06/02/2010EP2190293A1 Compounds and methods for treating zinc matrix metalloprotease dependent diseases
06/02/2010EP2032563B1 Benzimidazol substituted thiophene derivatives with activity on plk
06/02/2010EP2001478B1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
06/02/2010EP1558571B1 Novel compounds useful in treating ppar mediated diseases
06/02/2010CN1809559B Pyrazole derivatives as phosphodiesterase 4 inhibitors
06/02/2010CN101720324A [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto
06/02/2010CN101720318A Quinazolin-oxime derivatives as hsp90 inhibitors
06/02/2010CN101717396A Triazine type photonic functional material and preparation and application method thereof
06/02/2010CN101717373A Diaryl urea derivative and application thereof
06/01/2010US7728152 Process for producing 2-benzoyloxyacetaldehyde derivative
06/01/2010US7728150 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
06/01/2010US7728146 dipeptidyl peptidase IV inhibitors, capable of crossing the blood-brain-barrier in mammals, useful for the treatment of neurological and neurodegenerative diseases, such as anxiety, depression and Alzheimer's disease
06/01/2010US7728022 (4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid derivatives for treatment of Alzheimer's disease
06/01/2010US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
06/01/2010US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
06/01/2010US7727511 Agents for imaging soluble a-beta
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010059922A1 Pyrrolidine carboxamide compounds
05/27/2010WO2010059611A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058512A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
05/27/2010WO2010057899A1 Cycloalkyl amino carbonyl derivatives as bradykinin-b1 receptor antagonists
05/27/2010WO2010057848A1 8-azabicyclo [3.2.1]oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors
05/27/2010WO2010057833A1 Compounds for treatment of duchenne muscular dystrophy
05/27/2010WO2010038081A3 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
05/27/2010WO2010017272A3 Method of treating neurological diseases